Adagio Medical Holdings, Inc. (ADGM:NASDAQ) closed at $1.93 on November 13, 2026, up 6.04% on the day. The stock trades 96.2% below its 52-week high of $50.70 and 28.7% above its 52-week low of $1.50. Adagio Medical Holdings, Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, ADGM closed higher on 104 days (41%). Its best day was August 4, 2026 (+73.91%) and its worst was September 23, 2026 (-53.09%). The stock moved 10% or more in a single session 27 times. It opened at least 5% above the previous day's high 6 times.
Adagio Medical, Inc., is a medical device company located in Laguna Hills, California. Co-founded in 2011 by Dr. James Cox, the inventor of gold standard Cox-Maze procedure, and Olav Bergheim, a serial entrepreneur, Adagio Medical is developing innovative ablation technologies for the treatment of cardiac arrhythmias including atrial fibrillation, atrial flutter, and ventricular tachycardia. Adagios unique portfolio is based on Ultra-Low Temperature Cryoablation (ULTC) and Pulsed-Field Cryoablation (PFCA) designed to produce durable, contiguous, transmural lesions anywhere in the heart.
Find more stocks like ADGM with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.